Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorHodkinson, Brendan P.
dc.contributor.authorSchaffer, Michael
dc.contributor.authorBrody, Joshua D.
dc.contributor.authorCarpio Segura, Cecilia Carmen
dc.contributor.authorBen-Yehuda, Dina
dc.contributor.authorJurczak, Wojciech
dc.date.accessioned2021-06-14T12:41:37Z
dc.date.available2021-06-14T12:41:37Z
dc.date.issued2021-01
dc.identifier.citationHodkinson BP, Schaffer M, Brody JD, Jurczak W, Carpio C, Ben-Yehuda D, et al. Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter’s transformation. Transl Oncol. 2021 Jan;14(1):100977.
dc.identifier.issn1936-5233
dc.identifier.urihttps://hdl.handle.net/11351/6069
dc.descriptionBiomarcadors; Ibrutinib; Limfoma no hodgkin
dc.description.sponsorshipSponsored by Janssen Research & Development, LLC.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesTranslational Oncology;14(1)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectLimfomes
dc.subjectMedicaments antineoplàstics
dc.subjectMarcadors bioquímics
dc.subject.meshLymphoma
dc.subject.meshDrug Therapy, Combination
dc.subject.meshBiomarkers
dc.titleBiomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.tranon.2020.100977
dc.subject.decslinfoma
dc.subject.decsfarmacoterapia combinada
dc.subject.decsbiomarcadores
dc.relation.publishversionhttps://www.sciencedirect.com/science/article/pii/S1936523320304691
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Hodkinson BP, Schaffer M] Oncology Translational Research, Janssen Research & Development, Spring House, PA 19477, United States. [Brody JD] Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States. [Jurczak W] Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, 31-115, Poland. [Carpio C] Servei d’Hematologia i hemoteràpia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Ben-Yehuda D] Department of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel
dc.identifier.pmid33395752
dc.identifier.wos000604582000003
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple